Core Viewpoint - Dali Long (002209) has signed a new contract with Jiangsu Shangshou Biotechnology Co., Ltd. for a 48,000 BPH embryo chemical dry sterilization line, following a previous contract for a 24,000 BPH line in January 2024. The company's technology significantly reduces packaging sterilization energy consumption by over 80% compared to traditional wet methods [1] Summary by Category Company Developments - Dali Long has secured a contract for a 48,000 BPH embryo chemical dry sterilization line with Jiangsu Shangshou Biotechnology Co., Ltd. [1] - This follows an earlier agreement in January 2024 for a 24,000 BPH line, indicating a growing partnership and demand for Dali Long's technology [1] Industry Impact - The introduction of Dali Long's embryo chemical dry sterilization line represents a significant advancement in sterilization technology, reducing energy consumption by over 80% compared to traditional methods [1]